This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Understand the key risks the SP 500 presents to retirees and how volatility can impact withdrawal plans and long-term goals. This intro covers market exposure and practical safeguards.
17,139 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Protests ignite in Nairobi as fuel costs surge and a transport strike widens disrupted daily life; schools shift onli...
Arm is catching renewed investor attention as data-center demand for energy-efficient CPUs grows. Analysts say arm’s ...
Caterpillar sits at the crossroads of infrastructure demand and cyclical risk. This guide helps should dividend stock...
AI disruption is reshaping entry-level jobs, pushing the next generation to consider space-based careers. This report...
When a top investor takes a sizable stake in a marquee stock, it grabs attention. This piece breaks down what billion...
A mixed quarter and a tougher backdrop pushed KE Holdings shares lower, underscoring how market forces and sector hea...
A surprise stake in Marriott Vacations Worldwide has investors weighing whether marriott stock after capital offers a...
AMD has delivered a dramatic rally this year, but the big question remains: is the move sustainable? This article bre...
Wells Fargo agreed to a $110 million discrimination settlement, prompting a cautious but constructive market response...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...